Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,137.50    20.50 (1.84%)
Bid:
1,129.50
Ask:
1,132.50
Spread: 3.00 (0.266%)
Market Cap: £4.09b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Director/PDMR Shareholding

20 Dec 2024 15:33

RNS Number : 9968Q
Burberry Group PLC
20 December 2024
 

Burberry Group plc (the "Company") - Director/PDMR Shareholdings

 

 

As announced on 15 July 2024, as part of his appointment, Joshua Schulman, Chief Executive Officer (the "CEO") of the Company, is to receive a recruitment share award over Ordinary Shares of 0.05p each ("Shares") in the Company. Accordingly, the Company announces that a conditional share award was granted on 19 December 2024 to Joshua Schulman as detailed below (the "Recruitment Award"):

 

Director

Number of Shares subject to Recruitment Award

Award type

Vesting date

Terms

Joshua Schulman

392,366

Performance-based award

17 July 2027

 

 

Bespoke award in reliance on FCA Listing Rule 9.3.2(2) to facilitate recruitment, on terms similar to Burberry Share Plan 2020 awards.

 

The number of Shares comprised in the Recruitment Award was determined by reference to the Company's share price using the 20-business day average prior to the date of Joshua's appointment (917.51p). The Recruitment Award is subject to the achievement of performance conditions linked to the Company's absolute Total Shareholder Return (TSR) and a two-year post-vesting holding period.

 

Vesting will be subject to the following vesting profile: 

 

% of award vesting

(rounded down to nearest whole Share)

Absolute TSR

Threshold

25%

+49%

Maximum

100%

+109%

 

The Recruitment Award has been made in line with the Company's Directors' Remuneration Policy, which is set out in full in the FY 2022/23 Directors' Remuneration Report.

 

Full details of the Recruitment Award, including further details of the performance conditions and information as required by FCA Listing Rule 9.3.3, will be set out in the Company's FY 2024/25 Directors' Remuneration Report.

 

20 December 2024

 

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 as it forms part of UK law.

Notification of dealing form

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Joshua Schulman

2

Reason for the notification

a)

Position/status

Chief Executive Officer 

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Burberry Group plc

b)

LEI

213800PE1KEFCNFR1R50

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.05 pence each ("Shares")

 

 

GB0031743007

b)

Nature of the transaction

Grant of a conditional award over Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

 

392,366

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Aggregate Price

Aggregate Volume

Aggregate

Total

Nil

 

392,366

Nil

e)

Date of the transaction

2024-12-19

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFEFALIFIS
Date   Source Headline
10th Jun 20264:52 pmRNSDirector Declaration
9th Jun 202611:30 amRNSHolding(s) in Company
1st Jun 202610:15 amRNSIssue of Shares & Total Voting Rights
28th May 202610:45 amRNSAnnual Financial Report
14th May 20267:01 amRNSBoard changes
14th May 20267:00 amRNSBurberry FY26 Preliminary Results
1st May 202612:20 pmRNSIssue of Shares & Total Voting Rights
29th Apr 20262:45 pmRNSDirector Declaration
10th Apr 20263:40 pmRNSHolding(s) in Company
9th Apr 202611:30 amRNSHolding(s) in Company
1st Apr 20265:30 pmRNSIssue of Shares & Total Voting Rights
1st Apr 202612:15 pmRNSHolding(s) in Company
20th Mar 202612:31 pmRNSDirector/PDMR Shareholding
20th Mar 202610:25 amRNSIssue of Equity
19th Mar 20266:00 pmRNSHolding(s) in Company
5th Mar 20264:40 pmRNSHolding(s) in Company
2nd Mar 202611:00 amRNSTotal Voting Rights
12th Feb 20262:00 pmRNSHolding(s) in Company
10th Feb 202610:30 amRNSHolding(s) in Company
2nd Feb 20262:00 pmRNSTotal Voting Rights
27th Jan 20265:00 pmRNSHolding(s) in Company
22nd Jan 202612:30 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSThird Quarter Trading Update
9th Jan 202612:30 pmRNSHolding(s) in Company
2nd Jan 202611:30 amRNSTotal Voting Rights
18th Dec 20252:01 pmRNSHolding(s) in Company
18th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20259:15 amRNSDirector/PDMR Shareholding
2nd Dec 20255:40 pmRNSHolding(s) in Company
1st Dec 20251:30 pmRNSTotal Voting Rights
24th Nov 20255:30 pmRNSHolding(s) in Company
20th Nov 20254:20 pmRNSHolding(s) in Company
19th Nov 20255:36 pmRNSHolding(s) in Company
18th Nov 20256:07 pmRNSHolding(s) in Company
13th Nov 20255:27 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNSBurberry Interim Results
3rd Nov 20252:43 pmRNSTotal Voting Rights
28th Oct 20254:50 pmRNSHolding(s) in Company
15th Oct 20255:38 pmRNSHolding(s) in Company
10th Oct 202512:07 pmRNSHolding(s) in Company
2nd Oct 20253:10 pmRNSHolding(s) in Company
1st Oct 202510:30 amRNSTotal Voting Rights
25th Sep 20256:00 pmRNSHolding(s) in Company
5th Sep 20256:21 pmRNSBlock listing Interim Review
5th Sep 20255:45 pmRNSDirector/PDMR Shareholding
1st Sep 202512:14 pmRNSTotal Voting Rights
13th Aug 20253:04 pmRNSHolding(s) in Company
1st Aug 202511:58 amRNSTotal Voting Rights
31st Jul 20254:55 pmRNSDirector/PDMR Shareholding
18th Jul 20255:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.